<DOC>
	<DOCNO>NCT00912171</DOCNO>
	<brief_summary>The aim project evaluate whether therapy leukotriene may valid therapeutic approach child adenotonsillar hypertrophy mild moderate obstructive sleep apnea syndrome ( OSAS ) evaluate whether leukotriene le , equally efficient nasal steroid .</brief_summary>
	<brief_title>Efficacy Oral Leukotriene Long Term Therapy Mild Moderate Obstructive Sleep Apnea Syndrome Children</brief_title>
	<detailed_description>The aim project evaluate whether leukotriene le , equally efficient nasal steroid child adenotonsillar hypertrophy mild moderate OSAS check leukotriene administrate 24 week improve overnight oximetry , polysomnography check leukotriene anti-inflammatory upper airway really reduce tonsil adenoid dimension .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Leukotriene Antagonists</mesh_term>
	<criteria>Diagnosis mild ( RDI 3 &lt; 5 ) moderate obstructive apnea ( RDI 58 ) overnight polysomnographic evaluation 4 channel EEG Adenotonsillar hypertrophy Friedman score 's IIIIIIVÂ° Neuromuscular , gastrointestinal , neurological disease syndromes malformation Use leukotrienes and/or nasal oral steroid 4 week precede initial sleep study Acute upper respiratory tract infection Adenotonsillectomy</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>obstructive sleep apnea syndrome</keyword>
	<keyword>snore</keyword>
	<keyword>adenotonsillar hypertrophy</keyword>
	<keyword>polysomnography</keyword>
	<keyword>intranasal steroid</keyword>
	<keyword>Anti-leukotrienes</keyword>
</DOC>